Clinical trial
Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease…
NCT00029731 · UCSF Benioff Children's Hospital Oakland, Other · Completed
Key facts
| NCT number | NCT00029731 |
|---|---|
| Title | Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients |
| Official title | Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease |
| Lead sponsor | UCSF Benioff Children's Hospital Oakland, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Sickle Cell, Pneumonia |
| Intervention type | Drug |
| Interventions | Arginine hydrochloride |
| Enrollment | 30 |
| Start date | Aug 1, 2001 |
| Completion | Jul 1, 2005 |
| First posted | Jan 22, 2002 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: